Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Mechanistic insights into polycystic ovary syndrome and periodontal disease: a systematic scoping review of inflammatory, oxidative stress, hormonal-metabolic, and microbial pathways.

Created on 27 Oct 2026

Authors

Mustafa Nassar, Yasmina Zatar, Nino Sharikadze, Tamar Aladashvili, Eka Kokhreidze

Published in

The Saudi dental journal. Volume 38. Issue 11. Oct 26, 2026. Epub Oct 26, 2026.

Abstract

To identify critical evidence gaps, this scoping review mapped the extent and nature of published research exploring the biological links between polycystic ovary syndrome (PCOS) and periodontal disease. Following PRISMA-ScR guidelines and a pre-registered protocol (OSF: https://doi.org/10.17605/OSF.IO/WE3XU) a systematic search of PubMed, Scopus, EBSCO, and Google Scholar identified original human studies assessing clinical periodontal parameters and mechanistic biomarkers in PCOS patients. Screening and data extraction were conducted independently by two reviewers. Thirty-three studies met the inclusion criteria. Mapping identified a synergistic pathophysiological network across four domains. The evidence reveals an elevated systemic inflammatory baseline marked by hyper-activated endothelial markers (Endocan) alongside elevated levels of Tumor Necrosis Factor-alpha (TNF-alpha) and Interleukin-6 (IL-6), which appears to lower the threshold for local tissue destruction. This is coupled with a compromised antioxidant defense-notably nuclear factor erythroid 2-related factor 2 (NRF2) downregulation-and a "microbial dysbiosis" toward pathogenic microbial complexes. However, current data primarily identify mechanistic intersections rather than definitive causality, with the "PCOS-specific" impact often confounded by shared metabolic risk factors like insulin resistance and adiposity. Mapping this evidence reveals a profound overlap between PCOS and periodontitis through shared pathophysiological networks. Advancing this field requires a Core Outcome Set (COS) and well-designed randomized controlled trials. Clinically, recognizing periodontal disease as a potential contributor to the systemic inflammatory burden suggests that integrating routine.

PMID:
42932123
Bibliographic data and abstract were imported from PubMed on 27 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 25
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement